UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$694M |
| 2 |
Apple
AAPL
|
+$615M |
| 3 |
NVIDIA
NVDA
|
+$609M |
| 4 |
Eli Lilly
LLY
|
+$569M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$1.07B |
| 2 |
Tesla
TSLA
|
+$467M |
| 3 |
iShares MSCI ACWI ETF
ACWI
|
+$262M |
| 4 |
Match Group
MTCH
|
+$241M |
| 5 |
Valero Energy
VLO
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.89% |
| 2 | Financials | 8.35% |
| 3 | Healthcare | 6.45% |
| 4 | Consumer Discretionary | 5.39% |
| 5 | Communication Services | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Celldex Therapeutics
CLDX
$3.28B
| $5.66M | ﹤0.01% |
166,597
+6,001
| +4% | +$229K |
|
|
HTO
2952
H2O America
HTO
$2.62B
| $5.66M | ﹤0.01% |
97,398
+4,141
| +4% | +$242K |
|
2953
Qfin Holdings
QFIN
$1.61B
| $5.65M | ﹤0.01% |
189,390
-1,560,732
| -89% | -$35.6M |
|
2954
Universal Corp
UVV
$1.27B
| $5.64M | ﹤0.01% |
106,105
+20,345
| +24% | +$1.05M |
|
2955
VanEck Short Muni ETF
SMB
$312M
| $5.62M | ﹤0.01% |
325,123
-84
| -0% | -$1.44K |
|
|
PCH
2956
DELISTED
PotlatchDeltic
PCH
| $5.61M | ﹤0.01% |
124,578
+64,565
| +108% | +$2.73M |
|
2957
Gulfport Energy Corp
GPOR
$2.88B
| $5.61M | ﹤0.01% |
37,054
-9,054
| -20% | -$1.33M |
|
2958
PennyMac Financial
PFSI
$4.02B
| $5.61M | ﹤0.01% |
49,204
+22,365
| +83% | +$2.29M |
|
2959
iShares Intermediate Government/Credit Bond ETF
GVI
$3.78B
| $5.6M | ﹤0.01% |
52,289
+9,662
| +23% | +$1.02M |
|
2960
SM Energy
SM
$6.87B
| $5.6M | ﹤0.01% |
140,101
+17,229
| +14% | +$747K |
|
2961
John Wiley & Sons Class A
WLY
$2.66B
| $5.6M | ﹤0.01% |
116,046
+39,001
| +51% | +$1.79M |
|
2962
Avista
AVA
$3.24B
| $5.6M | ﹤0.01% |
144,451
+21,644
| +18% | +$818K |
|
2963
ONE Gas
OGS
$5.04B
| $5.59M | ﹤0.01% |
75,179
+39,842
| +113% | +$2.74M |
|
2964
Korn Ferry
KFY
$4.28B
| $5.59M | ﹤0.01% |
74,337
+32,120
| +76% | +$2.25M |
|
2965
Phillips Edison & Co
PECO
$5.24B
| $5.59M | ﹤0.01% |
148,148
+104,223
| +237% | +$3.72M |
|
2966
Myriad Genetics
MYGN
$312M
| $5.59M | ﹤0.01% |
203,959
+82,072
| +67% | +$2.22M |
|
|
TPH
2967
DELISTED
Tri Pointe Homes
TPH
| $5.57M | ﹤0.01% |
122,937
+44,195
| +56% | +$1.89M |
|
2968
Madison Square Garden
MSGS
$9.39B
| $5.56M | ﹤0.01% |
26,704
+4,196
| +19% | +$844K |
|
2969
Invesco Biotechnology & Genome ETF
PBE
$292M
| $5.55M | ﹤0.01% |
79,462
+3,518
| +5% | +$244K |
|
2970
ProShares UltraPro S&P 500
UPRO
$5.7B
| $5.54M | ﹤0.01% |
64,323
+63,938
| +16,607% | +$5.02M |
|
2971
Davis Select Worldwide ETF
DWLD
$613M
| $5.54M | ﹤0.01% |
146,158
-426
| -0.3% | -$14.5K |
|
2972
Churchill Downs
CHDN
$6.12B
| $5.54M | ﹤0.01% |
40,963
-4,193
| -9% | -$580K |
|
2973
iShares Core MSCI Pacific ETF
IPAC
$2.77B
| $5.53M | ﹤0.01% |
83,110
-334
| -0.4% | -$21.1K |
|
2974
10x Genomics
TXG
$6.61B
| $5.53M | ﹤0.01% |
244,754
+93,197
| +61% | +$1.93M |
|
2975
AutoNation
AN
$6.92B
| $5.52M | ﹤0.01% |
30,864
+14,799
| +92% | +$2.54M |
|
Similar funds
UBS Group's Q3 2024 Portfolio in Review
As of Q3 2024, UBS Group held 10,551 positions worth $459B, up 13% from $405B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
UBS Group deployed $30.4B of net new capital in Q3 2024, opening 1,098 new positions and adding to 4,837 existing holdings. Its largest new stake was Smurfit Westrock: 973,061 shares worth $48.1M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Nike, an estimated $1.07B trimmed.
- UBS Group's largest Q3 2024 buy was Smurfit Westrock: 973,061 shares worth $48.1M.
- UBS Group added most to Meta Platforms (Facebook) in Q3 2024, an estimated $694M increase.
- UBS Group's biggest Q3 2024 reduction was Nike, cutting an estimated $1.07B.
- UBS Group fully exited WestRock Company in Q3 2024, selling an estimated $161M.
- UBS Group's ten largest holdings make up 17% of its $459B portfolio in Q3 2024.
- UBS Group opened 1,098 new positions and closed 1,108 in Q3 2024.
- UBS Group's portfolio value rose 13% quarter-over-quarter to $459B.
Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.